how much is semaglutide from hims Just Launched an Ozempic Dupe Novo Nordisk ends Hims &

GLP-1s Make Weight Loss Easier And More Attainable Now

doi: 10.1093/jn/nxac026 Yamada T, Shintani T, Iida T, Kishimoto Y, Okuma K

The WHO released its first global guideline for GLP-1 obesity treatment, recognizing obesity as a chronic disease

Laborde Earles Injury Lawyers helps injured patients pursue justice and compensation across Louisiana

Practical takeaway Until stronger evidence exists, the review argues the path forward is collaborative pregnancy registries + better real-world data, so inadvertent exposures can be counselled with confidenceand so we can finally test whether pharmacotherapy could ever play a role in carefully selected high-risk cases